 | • レポートコード：B-GIR09D3994 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、緑内障治療の世界市場について調べ、まとめました。種類別セグメントは、プロスタグランジンアナログ（PGA）、ベータブロッカー、アルファアゴニスト等、用途別セグメントは、クリニック、薬局、その他等に区分しました。緑内障治療の世界市場概観、企業動向、企業別緑内障治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・緑内障治療の市場概観 ・緑内障治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・緑内障治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・緑内障治療の世界市場規模 ・緑内障治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・緑内障治療のアメリカ市場規模推移 ・緑内障治療のカナダ市場規模推移 ・緑内障治療のメキシコ市場規模推移 ・緑内障治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・緑内障治療のドイツ市場規模推移 ・緑内障治療のイギリス市場規模推移 ・緑内障治療のロシア市場規模推移 ・緑内障治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・緑内障治療の日本市場規模推移 ・緑内障治療の中国市場規模推移 ・緑内障治療の韓国市場規模推移 ・緑内障治療のインド市場規模推移 ・緑内障治療の東南アジア市場規模推移 ・緑内障治療の南米市場分析（ブラジル、アルゼンチン等） ・緑内障治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・緑内障治療の種類別分析/販売量、売上、市場シェア（プロスタグランジンアナログ（PGA）、ベータブロッカー、アルファアゴニスト） ・緑内障治療の用途別分析/市場規模（クリニック、薬局、その他） ・緑内障治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・緑内障治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
Glaucoma can be treated with eye drops, pills, laser surgery, traditional surgery or a combination of these methods. The goal of any treatment is to prevent loss of vision, as vision loss from glaucoma is irreversible.
Scope of the Report:
In the last several years, Hong Kong market of Glaucoma Treatment developed rapidly, with an average growth rate of 4% during 2013 to 2018. In 2018, Hong Kong revenue of Glaucoma Treatment is nearly 73 M USD.
The classification of Glaucoma Treatment includes Prostaglandin Analogs (PGAs), Beta Blocker, Alpha Agonist and other, and the proportion of Prostaglandin Analogs (PGAs) in 2018 is about 52%, and the proportion is in increasing trend from 2013 to 2018.
Glaucoma Treatment is widely used in Clinic, Pharmacy and other field. The most proportion of Glaucoma Treatment is in hospitals, and the proportion in 2018 is 66%.
The global Glaucoma Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Glaucoma Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Glaucoma Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Glaucoma Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Novartis
Allergan
Pfizer
Akorn
Teva
Bausch & Lomb
Otsuka Pharmaceutical
Santen
Lunan Pharma
Zizhu Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Prostaglandin Analogs (PGAs)
Beta Blocker
Alpha Agonist
Market Segment by Applications, can be divided into
Clinic
Pharmacy
Other
Table of Contents
1 Glaucoma Treatment Market Overview
1.1 Product Overview and Scope of Glaucoma Treatment
1.2 Classification of Glaucoma Treatment by Types
1.2.1 Global Glaucoma Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Glaucoma Treatment Revenue Market Share by Types in 2018
1.2.3 Prostaglandin Analogs (PGAs)
1.2.4 Beta Blocker
1.2.5 Alpha Agonist
1.3 Global Glaucoma Treatment Market by Application
1.3.1 Global Glaucoma Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Clinic
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Glaucoma Treatment Market by Regions
1.4.1 Global Glaucoma Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Glaucoma Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Glaucoma Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Glaucoma Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Glaucoma Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Glaucoma Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Glaucoma Treatment (2014-2024)
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Glaucoma Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Allergan
2.2.1 Business Overview
2.2.2 Glaucoma Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Allergan Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Glaucoma Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Akorn
2.4.1 Business Overview
2.4.2 Glaucoma Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Akorn Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Teva
2.5.1 Business Overview
2.5.2 Glaucoma Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Teva Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Bausch & Lomb
2.6.1 Business Overview
2.6.2 Glaucoma Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bausch & Lomb Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Otsuka Pharmaceutical
2.7.1 Business Overview
2.7.2 Glaucoma Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Otsuka Pharmaceutical Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Santen
2.8.1 Business Overview
2.8.2 Glaucoma Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Santen Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 Lunan Pharma
2.9.1 Business Overview
2.9.2 Glaucoma Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Lunan Pharma Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.10 Zizhu Pharma
2.10.1 Business Overview
2.10.2 Glaucoma Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Zizhu Pharma Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Glaucoma Treatment Market Competition, by Players
3.1 Global Glaucoma Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Glaucoma Treatment Players Market Share
3.2.2 Top 10 Glaucoma Treatment Players Market Share
3.3 Market Competition Trend
4 Global Glaucoma Treatment Market Size by Regions
4.1 Global Glaucoma Treatment Revenue and Market Share by Regions
4.2 North America Glaucoma Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Glaucoma Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Glaucoma Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Glaucoma Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Glaucoma Treatment Revenue and Growth Rate (2014-2019)
5 North America Glaucoma Treatment Revenue by Countries
5.1 North America Glaucoma Treatment Revenue by Countries (2014-2019)
5.2 USA Glaucoma Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Glaucoma Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Glaucoma Treatment Revenue and Growth Rate (2014-2019)
6 Europe Glaucoma Treatment Revenue by Countries
6.1 Europe Glaucoma Treatment Revenue by Countries (2014-2019)
6.2 Germany Glaucoma Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Glaucoma Treatment Revenue and Growth Rate (2014-2019)
6.4 France Glaucoma Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Glaucoma Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Glaucoma Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Glaucoma Treatment Revenue by Countries
7.1 Asia-Pacific Glaucoma Treatment Revenue by Countries (2014-2019)
7.2 China Glaucoma Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Glaucoma Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Glaucoma Treatment Revenue and Growth Rate (2014-2019)
7.5 India Glaucoma Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Glaucoma Treatment Revenue and Growth Rate (2014-2019)
8 South America Glaucoma Treatment Revenue by Countries
8.1 South America Glaucoma Treatment Revenue by Countries (2014-2019)
8.2 Brazil Glaucoma Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Glaucoma Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Glaucoma Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Glaucoma Treatment by Countries
9.1 Middle East and Africa Glaucoma Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Glaucoma Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Glaucoma Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Glaucoma Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Glaucoma Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Glaucoma Treatment Revenue and Growth Rate (2014-2019)
10 Global Glaucoma Treatment Market Segment by Type
10.1 Global Glaucoma Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Glaucoma Treatment Market Forecast by Type (2019-2024)
10.3 Prostaglandin Analogs (PGAs) Revenue Growth Rate (2014-2024)
10.4 Beta Blocker Revenue Growth Rate (2014-2024)
10.5 Alpha Agonist Revenue Growth Rate (2014-2024)
11 Global Glaucoma Treatment Market Segment by Application
11.1 Global Glaucoma Treatment Revenue Market Share by Application (2014-2019)
11.2 Glaucoma Treatment Market Forecast by Application (2019-2024)
11.3 Clinic Revenue Growth (2014-2019)
11.4 Pharmacy Revenue Growth (2014-2019)
11.5 Other Revenue Growth (2014-2019)
12 Global Glaucoma Treatment Market Size Forecast (2019-2024)
12.1 Global Glaucoma Treatment Market Size Forecast (2019-2024)
12.2 Global Glaucoma Treatment Market Forecast by Regions (2019-2024)
12.3 North America Glaucoma Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Glaucoma Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Glaucoma Treatment Revenue Market Forecast (2019-2024)
12.6 South America Glaucoma Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Glaucoma Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Glaucoma Treatment Picture
Table Product Specifications of Glaucoma Treatment
Table Global Glaucoma Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Glaucoma Treatment Revenue Market Share by Types in 2018
Figure Prostaglandin Analogs (PGAs) Picture
Figure Beta Blocker Picture
Figure Alpha Agonist Picture
Table Global Glaucoma Treatment Revenue (Million USD) by Application (2014-2024)
Figure Glaucoma Treatment Revenue Market Share by Applications in 2018
Figure Clinic Picture
Figure Pharmacy Picture
Figure Other Picture
Table Global Market Glaucoma Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Glaucoma Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Glaucoma Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Glaucoma Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Glaucoma Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Glaucoma Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Glaucoma Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Glaucoma Treatment Type and Applications
Table Novartis Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Glaucoma Treatment Type and Applications
Table Allergan Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Glaucoma Treatment Type and Applications
Table Pfizer Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Akorn Basic Information, Manufacturing Base and Competitors
Table Akorn Glaucoma Treatment Type and Applications
Table Akorn Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Glaucoma Treatment Type and Applications
Table Teva Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Bausch & Lomb Basic Information, Manufacturing Base and Competitors
Table Bausch & Lomb Glaucoma Treatment Type and Applications
Table Bausch & Lomb Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Otsuka Pharmaceutical Glaucoma Treatment Type and Applications
Table Otsuka Pharmaceutical Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Santen Basic Information, Manufacturing Base and Competitors
Table Santen Glaucoma Treatment Type and Applications
Table Santen Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Lunan Pharma Basic Information, Manufacturing Base and Competitors
Table Lunan Pharma Glaucoma Treatment Type and Applications
Table Lunan Pharma Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Zizhu Pharma Basic Information, Manufacturing Base and Competitors
Table Zizhu Pharma Glaucoma Treatment Type and Applications
Table Zizhu Pharma Glaucoma Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Glaucoma Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Glaucoma Treatment Revenue Share by Players (2014-2019)
Figure Global Glaucoma Treatment Revenue Share by Players in 2017
Figure Global Glaucoma Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Glaucoma Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Glaucoma Treatment Revenue Market Share in 2018
Figure Global Glaucoma Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Glaucoma Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Glaucoma Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Glaucoma Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Glaucoma Treatment Revenue Market Share by Regions in 2018
Figure North America Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Figure South America Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Table North America Glaucoma Treatment Revenue by Countries (2014-2019)
Table North America Glaucoma Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Glaucoma Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Glaucoma Treatment Revenue Market Share by Countries in 2018
Figure USA Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Table Europe Glaucoma Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Glaucoma Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Glaucoma Treatment Revenue Market Share by Countries in 2018
Figure Germany Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Figure UK Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Figure France Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Glaucoma Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Glaucoma Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Glaucoma Treatment Revenue Market Share by Countries in 2018
Figure China Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Figure India Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Table South America Glaucoma Treatment Revenue by Countries (2014-2019)
Table South America Glaucoma Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Glaucoma Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Glaucoma Treatment Revenue Market Share by Countries in 2018
Figure Brazil Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Glaucoma Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Glaucoma Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Glaucoma Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Glaucoma Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Glaucoma Treatment Revenue and Growth Rate (2014-2019)
Table Global Glaucoma Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Glaucoma Treatment Revenue Share by Type (2014-2019)
Figure Global Glaucoma Treatment Revenue Share by Type (2014-2019)
Figure Global Glaucoma Treatment Revenue Share by Type in 2019
Table Global Glaucoma Treatment Revenue Forecast by Type (2019-2024)
Figure Global Glaucoma Treatment Market Share Forecast by Type (2019-2024)
Figure Global Prostaglandin Analogs (PGAs) Revenue Growth Rate (2014-2019)
Figure Global Beta Blocker Revenue Growth Rate (2014-2019)
Figure Global Alpha Agonist Revenue Growth Rate (2014-2019)
Table Global Glaucoma Treatment Revenue by Application (2014-2019)
Table Global Glaucoma Treatment Revenue Share by Application (2014-2019)
Figure Global Glaucoma Treatment Revenue Share by Application (2014-2019)
Figure Global Glaucoma Treatment Revenue Share by Application in 2019
Table Global Glaucoma Treatment Revenue Forecast by Application (2019-2024)
Figure Global Glaucoma Treatment Market Share Forecast by Application (2019-2024)
Figure Global Clinic Revenue Growth Rate (2014-2019)
Figure Global Pharmacy Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Glaucoma Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Glaucoma Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Glaucoma Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Glaucoma Treatment Revenue Market Forecast (2019-2024)
Figure Europe Glaucoma Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Glaucoma Treatment Revenue Market Forecast (2019-2024)
Figure South America Glaucoma Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Glaucoma Treatment Revenue Market Forecast (2019-2024)
微小侵襲緑内障手術装置市場：世界及び中国市場分析・予測（～2024年） Micro Invasive Glaucoma Surgery Devices Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Micro Invasive Glaucoma Surgery Devices industry with a focus on the Chinese market. The report provides key statistics on the market stat…- 世界の腱炎治療市場予測（～2024年） Tendinitis is irritation or inflammation of a tendon, a thick cord that attaches muscle to bone. Tendinitis is also called tendonitis. Tendinitis mainly caused due to sudden injury or activities that put stress on the tendons. Scope of the Report: The global Tendinitis Treatment market is valued at …
- 世界の髄膜炎菌感染症治療市場予測（～2024年） Meningococcal meningitis are a major cause of bacterial meningitis and septicemia, usually occurs during infancy, adolescence and young adulthood and is characterized by an infectious syndrome with meningismus. Aggressive early treatment of meningococcal disease can reduce mortality. Scope of the Re…
- 世界のアナフィラキシー治療市場予測（～2024年） Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death. It typically causes more than one of the following: an itchy rash, throat or tongue swelling, shortness of breath, vomiting, lightheadedness, and low blood pressure. These symptoms typically come on over minutes t…
- 世界のレフサム病治療市場予測（～2024年） Refsum disease, also known as classic or adult Refsum disease, heredopathia atactica polyneuritiformis, phytanic acid oxidase deficiency and phytanic acid storage disease, is an autosomal recessive neurological disease that results in the over-accumulation of phytanic acid in cells and tissues. Scop…